These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 1527321)

  • 1. Clinical correlation of the venom-specific IgG antibody level during maintenance venom immunotherapy.
    Golden DB; Lawrence ID; Hamilton RH; Kagey-Sobotka A; Valentine MD; Lichtenstein LM
    J Allergy Clin Immunol; 1992 Sep; 90(3 Pt 1):386-93. PubMed ID: 1527321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings.
    Ewan PW; Deighton J; Wilson AB; Lachmann PJ
    Clin Exp Allergy; 1993 Aug; 23(8):647-60. PubMed ID: 8221268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of prolonged venom immunotherapy in children.
    Graft DF; Schuberth KC; Kagey-Sobotka A; Kwiterovich KA; Niv Y; Lichtenstein LM; Valentine MD
    J Allergy Clin Immunol; 1987 Aug; 80(2):162-9. PubMed ID: 3611537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme-linked immunosorbent assay (ELISA) of changes in specific IgG antibodies to five venoms during venom immunotherapy.
    Hunt KJ; Askenase PW
    Clin Allergy; 1985 Jan; 15(1):17-27. PubMed ID: 3884178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse reactions to venom immunotherapy.
    Ramirez DA; Londono S; Evans R
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the allergenicity and antigenicity of yellow jacket and hornet venoms.
    Reisman RE; Mueller U; Wypych J; Elliott W; Arbesman CE
    J Allergy Clin Immunol; 1982 Mar; 69(3):268-74. PubMed ID: 6801104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of an in-hospital insect sting challenge as a criterion for application or omission of venom immunotherapy.
    Blaauw PJ; Smithuis OL; Elbers AR
    J Allergy Clin Immunol; 1996 Jul; 98(1):39-47. PubMed ID: 8765816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients.
    Fricker M; Helbling A; Schwartz L; Müller U
    J Allergy Clin Immunol; 1997 Jul; 100(1):11-5. PubMed ID: 9257781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance venom immunotherapy administered at 3-month intervals is both safe and efficacious.
    Goldberg A; Confino-Cohen R
    J Allergy Clin Immunol; 2001 May; 107(5):902-6. PubMed ID: 11344360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-like immunosorbent assay (ELISA) for immunoglobulin G antibodies against insect venoms.
    Grant JA; Goldblum RM; Rahr R; Thueson DO; Farnam J; Gillaspy J
    J Allergy Clin Immunol; 1981 Aug; 68(2):112-8. PubMed ID: 6166648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy.
    Golden DB; Meyers DA; Kagey-Sobotka A; Valentine MD; Lichtenstein LM
    J Allergy Clin Immunol; 1982 Jun; 69(6):489-93. PubMed ID: 7076990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and immunologic follow-up of patients who stop venom immunotherapy.
    Keating MU; Kagey-Sobotka A; Hamilton RG; Yunginger JW
    J Allergy Clin Immunol; 1991 Sep; 88(3 Pt 1):339-48. PubMed ID: 1890261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stinging insect allergy: natural history and modification with venom immunotherapy.
    Reisman RE; Dvorin DJ; Randolph CC; Georgitis JW
    J Allergy Clin Immunol; 1985 Jun; 75(6):735-40. PubMed ID: 4008803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective observations on stopping prolonged venom immunotherapy.
    Golden DB; Addison BI; Gadde J; Kagey-Sobotka A; Valentine MD; Lichtenstein LM
    J Allergy Clin Immunol; 1989 Aug; 84(2):162-7. PubMed ID: 2760358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients.
    Sturm G; Kränke B; Rudolph C; Aberer W
    J Allergy Clin Immunol; 2002 Dec; 110(6):928-33. PubMed ID: 12464961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Desensitization of allergy to hymenoptera venoms].
    Przybilla B; Ruëff F
    Wien Med Wochenschr; 1999; 149(14-15):421-8. PubMed ID: 10584286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
    Ruëff F; Wenderoth A; Przybilla B
    J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG and IgE antibodies after immunotherapy with bee and wasp venom.
    Kemeny DM; Lessof MH; Patel S; Youlten LJ; Williams A; Lambourn E
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):247-9. PubMed ID: 2707888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibody response pattern (specific IgE and IgG) of insect sting allergic patients in immunotherapy with venom preparations].
    Wüthrich B; Arrendal H; Lanner A
    Schweiz Med Wochenschr; 1981 Nov; 111(46):1756-65. PubMed ID: 7313646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of immunotherapy with venom in children with allergy to insect stings.
    Valentine MD; Schuberth KC; Kagey-Sobotka A; Graft DF; Kwiterovich KA; Szklo M; Lichtenstein LM
    N Engl J Med; 1990 Dec; 323(23):1601-3. PubMed ID: 2098016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.